526 related articles for article (PubMed ID: 24238278)
1. Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction.
Peeters K; Sahai A; De Ridder D; Van Der Aa F
BJU Int; 2014 May; 113(5):789-94. PubMed ID: 24238278
[TBL] [Abstract][Full Text] [Related]
2. Sacral neuromodulation in diabetic patients: success and complications in the treatment of voiding dysfunction.
Daniels DH; Powell CR; Braasch MR; Kreder KJ
Neurourol Urodyn; 2010 Apr; 29(4):578-81. PubMed ID: 19760757
[TBL] [Abstract][Full Text] [Related]
3. Sacral neuromodulation in urological indications: the Finnish experience.
Vaarala MH; Tammela TL; Perttilä I; Luukkonen P; Hellström P
Scand J Urol Nephrol; 2011 Feb; 45(1):46-51. PubMed ID: 20961268
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of sacral neuromodulation for women with urinary retention.
Dasgupta R; Wiseman OJ; Kitchen N; Fowler CJ
BJU Int; 2004 Aug; 94(3):335-7. PubMed ID: 15291863
[TBL] [Abstract][Full Text] [Related]
5. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study.
van Kerrebroeck PE; van Voskuilen AC; Heesakkers JP; Lycklama á Nijholt AA; Siegel S; Jonas U; Fowler CJ; Fall M; Gajewski JB; Hassouna MM; Cappellano F; Elhilali MM; Milam DF; Das AK; Dijkema HE; van den Hombergh U
J Urol; 2007 Nov; 178(5):2029-34. PubMed ID: 17869298
[TBL] [Abstract][Full Text] [Related]
6. The long-term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centre.
Gajewski JB; Al-Zahrani AA
BJU Int; 2011 Apr; 107(8):1258-64. PubMed ID: 20883483
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of sacral neuromodulation with the tined lead procedure.
Marcelissen TA; Leong RK; de Bie RA; van Kerrebroeck PE; de Wachter SG
J Urol; 2010 Nov; 184(5):1997-2000. PubMed ID: 20850820
[TBL] [Abstract][Full Text] [Related]
8. Sacral nerve stimulation for voiding dysfunction: One institution's 11-year experience.
Sutherland SE; Lavers A; Carlson A; Holtz C; Kesha J; Siegel SW
Neurourol Urodyn; 2007; 26(1):19-28; discussion 36. PubMed ID: 17078071
[TBL] [Abstract][Full Text] [Related]
9. Sacral neuromodulation for neurogenic non-obstructive urinary retention in incomplete spinal cord patients: a ten-year follow-up single-centre experience.
Lombardi G; Musco S; Celso M; Del Corso F; Del Popolo G
Spinal Cord; 2014 Mar; 52(3):241-5. PubMed ID: 24394604
[TBL] [Abstract][Full Text] [Related]
10. Results of Sacral Neuromodulation Therapy for Urinary Voiding Dysfunction: Five-Year Experience of a Retrospective, Multicenter Study in China.
Zhang P; Wang JY; Zhang Y; Liao L; Lv JW; Ling Q; Wei ZQ; Zhong T; Xu ZH; Wen W; Li JY; Luo DY
Neuromodulation; 2019 Aug; 22(6):730-737. PubMed ID: 30609180
[TBL] [Abstract][Full Text] [Related]
11. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].
Hoda MR; Fornara P
Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609
[TBL] [Abstract][Full Text] [Related]
12. Sacral neuromodulation for refractory lower urinary tract dysfunction: results of a nationwide registry in Switzerland.
Kessler TM; Buchser E; Meyer S; Engeler DS; Al-Khodairy AW; Bersch U; Iselin CE; Roche B; Schmid DM; Schurch B; Zrehen S; Burkhard FC
Eur Urol; 2007 May; 51(5):1357-63. PubMed ID: 17113216
[TBL] [Abstract][Full Text] [Related]
13. Sacral neuromodulation for lower urinary tract dysfunction and impact on erectile function.
Lombardi G; Mondaini N; Giubilei G; Macchiarella A; Lecconi F; Del Popolo G
J Sex Med; 2008 Sep; 5(9):2135-40. PubMed ID: 18637993
[TBL] [Abstract][Full Text] [Related]
14. The value of urodynamic tools to guide patient selection in sacral neuromodulation.
Drossaerts J; Rademakers K; van Koeveringe G; Van Kerrebroeck P
World J Urol; 2015 Nov; 33(11):1889-95. PubMed ID: 25680936
[TBL] [Abstract][Full Text] [Related]
15. The presence of Fowler's syndrome predicts successful long-term outcome of sacral nerve stimulation in women with urinary retention.
De Ridder D; Ost D; Bruyninckx F
Eur Urol; 2007 Jan; 51(1):229-33; discussion 233-4. PubMed ID: 16860462
[TBL] [Abstract][Full Text] [Related]
16. Prolonged percutaneous SNM testing does not cause infection-related explanation.
Amend B; Bedke J; Khalil M; Stenzl A; Sievert KD
BJU Int; 2013 Mar; 111(3):485-91. PubMed ID: 22738331
[TBL] [Abstract][Full Text] [Related]
17. PNE versus 1st stage tined lead procedure: a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy.
Leong RK; De Wachter SG; Nieman FH; de Bie RA; van Kerrebroeck PE
Neurourol Urodyn; 2011 Sep; 30(7):1249-52. PubMed ID: 21404317
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of sacral neuromodulation on urological diseases: a multicentric research project.
Cardarelli S; D'Elia C; Cerruto MA; Curti P; Ostardo E; Signorello D; Pastorello M; Caleffi G; Molon A; Artibani W
Urologia; 2012; 79(2):90-6. PubMed ID: 22610844
[TBL] [Abstract][Full Text] [Related]
19. Secondary changes in bowel function after successful treatment of voiding symptoms with neuromodulation.
Killinger KA; Kangas JR; Wolfert C; Boura JA; Peters KM
Neurourol Urodyn; 2011 Jan; 30(1):133-7. PubMed ID: 20928914
[TBL] [Abstract][Full Text] [Related]
20. Onset of Action of Sacral Neuromodulation in Lower Urinary Tract Dysfunction-What is the Optimal Duration of Test Stimulation?
Jairam R; Drossaerts J; Marcelissen T; van Koeveringe G; van Kerrebroeck P
J Urol; 2018 Jun; 199(6):1584-1590. PubMed ID: 29291416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
